These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 31708068)
1. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies. Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068 [TBL] [Abstract][Full Text] [Related]
2. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies. Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016 [TBL] [Abstract][Full Text] [Related]
3. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Giesinger JM; Kieffer JM; Fayers PM; Groenvold M; Petersen MA; Scott NW; Sprangers MA; Velikova G; Aaronson NK; J Clin Epidemiol; 2016 Jan; 69():79-88. PubMed ID: 26327487 [TBL] [Abstract][Full Text] [Related]
4. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971 [TBL] [Abstract][Full Text] [Related]
5. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer. Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M; Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374 [TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the EORTC QLQ-C30 in Uganda. Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718 [TBL] [Abstract][Full Text] [Related]
7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191 [TBL] [Abstract][Full Text] [Related]
8. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients. McLachlan SA; Devins GM; Goodwin PJ Eur J Cancer; 1998 Mar; 34(4):510-7. PubMed ID: 9713301 [TBL] [Abstract][Full Text] [Related]
9. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Aaronson NK; Ahmedzai S; Bergman B; Bullinger M; Cull A; Duez NJ; Filiberti A; Flechtner H; Fleishman SB; de Haes JC J Natl Cancer Inst; 1993 Mar; 85(5):365-76. PubMed ID: 8433390 [TBL] [Abstract][Full Text] [Related]
10. The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES Registry. Husson O; de Rooij BH; Kieffer J; Oerlemans S; Mols F; Aaronson NK; van der Graaf WTA; van de Poll-Franse LV Oncologist; 2020 Apr; 25(4):e722-e732. PubMed ID: 32297435 [TBL] [Abstract][Full Text] [Related]
11. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26. Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B; BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889 [TBL] [Abstract][Full Text] [Related]
12. Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaire core 30 scores in patients with ovarian cancer. Musoro JZ; Coens C; Greimel E; King MT; Sprangers MAG; Nordin A; van Dorst EBL; Groenvold M; Cocks K; Velikova G; Flechtner HH; Bottomley A; Gynecol Oncol; 2020 Nov; 159(2):515-521. PubMed ID: 32972782 [TBL] [Abstract][Full Text] [Related]
13. Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients. Shen MH; Chen LP; Ho TF; Shih YY; Huang CS; Chie WC; Huang CC BMC Cancer; 2018 Apr; 18(1):353. PubMed ID: 29606101 [TBL] [Abstract][Full Text] [Related]
14. An international field study for the reliability and validity of the EORTC communication questionnaire EORTC QLQ-COMU26. Arraras JI; Giesinger J; Shamieh O; Bahar I; Koller M; Bredart A; Costantini A; Greimel E; Sztankay M; Wintner LM; de Sousa MC; Ishiki H; Kontogianni M; Wolan M; Kikawa Y; Lanceley A; Gioulbasanis I; Harle A; Zarandona U; Kulis D; Kuljanic K; Health Qual Life Outcomes; 2024 Oct; 22(1):87. PubMed ID: 39385305 [TBL] [Abstract][Full Text] [Related]
15. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals. Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM; BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611 [TBL] [Abstract][Full Text] [Related]
16. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20). Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV; Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189 [TBL] [Abstract][Full Text] [Related]
17. eCross-cultural adaptation of the spine oncology-specific SOSGOQ2.0 questionnaire to German language and the assessment of its validity and reliability in the clinical setting. Datzmann T; Kisel W; Kramer J; Dreimann M; Müller-Broich JD; Netzer C; Schaser KD; Schmitt J; Disch AC; BMC Cancer; 2021 Sep; 21(1):1044. PubMed ID: 34556063 [TBL] [Abstract][Full Text] [Related]
18. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China. Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985 [TBL] [Abstract][Full Text] [Related]
19. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module. Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847 [TBL] [Abstract][Full Text] [Related]
20. Normative data for the EORTC QLQ-C30 from the Austrian general population. Lehmann J; Giesinger JM; Nolte S; Sztankay M; Wintner LM; Liegl G; Rose M; Holzner B; Health Qual Life Outcomes; 2020 Aug; 18(1):275. PubMed ID: 32787854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]